Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
22
datasets available to search
ShareScore release 0.9.0
Dataset results
22 results for “SCAP”
Performance analysis & optimization of inverted inorganic CsGeI3 perovskite cells with carbon/copper charge transport materials using SCAPS‑1D
<p>Hybrid perovskite solar cells (PSC) have achieved efficiencies (PCE) of more than 25%. However, the organic compound is causing structural degradation due to heat and moisture. This has led to the exploration of inorganic perovskites. Inorganic-PSC such as cesium has seen a breakthrough by achieving highly stable PSC with PCE exceeding 15%. In this work, the inorganic non-toxic PSC of cesium germanium tri-iodide (CsGeI<sub>3</sub>) is numerically modeled in SCAPS-1D with two carbon-based and two copper-based charge transport layers(CTL). This study introduces in-depth modelling and analysis of CsGeI<sub>3</sub> through continuity and Poisson equations. Cu-CTL are selected to increase the electric conductivity of the cell, while carbon-CTL is used to increase the thermal conductivity. Four structures are designed and presented. A systematic approach is adopted to obtain the optimized design parameters for maximum performance. From the results it is observed that the C<sub>60</sub>/CsGeI<sub>3</sub>/CuSCN structure has the highest performance, with open-circuit voltage of 1.0169V, short-circuit current of 19.653 mA/Cm<sup>2</sup>, fill factor of 88.13% and PCE of 17.61%. Moreover, the effect of quantum efficiency, electric field, interface recombination, interface defects, layer thickness, defect density, doping concentration, working temperature and reflection coating on the cell performance are studied in detail.</p>
Performance analysis & optimization of inverted inorganic CsGeI3 perovskite cells with carbon/copper charge transport materials using SCAPS‑1D
Open the record for dataset details and reuse information.
The mortality risk factor of severe community-acquired pneumonia (SCAP) patients with Sepsis: a retrospective study
<p><strong><span>Objectives:</span></strong><span> Sepsis is one of the most common comorbidities in severe community-acquired pneumonia (SCAP) patients. We aimed to investigate the characteristics and mortality risk factors of SCAP patients hospitalized with Sepsis.</span></p> <p><strong><span>Design:</span></strong><span> A retrospective, single-centre study.</span></p> <p><strong><span>Setting:</span></strong><span> This study was conducted at a tertiary hospital in Southern China.</span></p> <p><strong><span>Participants:</span></strong><span> A total of 119 patients with SCAP, aged 17 years or older, were treated in the Integrated intensive care unit from 1 January 2018 to 30 December 2020.</span></p> <p><strong><span>Interventions:</span></strong><span> none.</span></p> <p><strong><span>Outcome:</span></strong><span> 180-day mortality was the primary outcome.</span></p> <p><span><strong>Results:</strong></span><span> 119 patients were divided into the survivors (83 patients,69.75%), and the non-survivors (36 patients,30.25%). There are more pronounced inflammatory responses and respiratory problems at the beginning of the disease in non-survivors, requiring stronger respiratory and circulatory support.</span> <span>The CURB-65 score was a better predictor of mortality than the PSI and APACHE2 scores, AUCs of CURB-65: OR 0.744, p<0.005.</span> <span>For the entire treatment cycle, the non-survivors had a longer duration of persistent fever, required continuous and repeated airway intervention, and a longer duration of Vasopressor support (P<0.001). SCAP with bacterial infection as the onset, </span><span>or secondary bacterial infection had a poor prognosis (P=0.018). The non-survivors had more use of different types of antimicrobials (P<0.05), because of Multidrug-resistant (MDR) organisms. And have faced more antifungal treatment failures (P=0.006). The</span> <span>mortality risk factors were comorbid with a duration of Vasopressors support, duration of persistent fever, age, numbers of antimicrobials for MDR organisms, CURB-65 score and duration of Neuromuscular Blocking Agents (NMBAs) (OR=1.234, OR=1.158, OR=1.084, OR=6.484, OR=3.386, OR=1.505, p<0.005, respectively).</span></p> <p><strong><span>Conclusion:</span></strong><span> Dynamic monitoring of the duration of patients' abnormal indicators can help predict the prognosis. Age≥65.5 years, fever duration ≥9.5 days, number of antimicrobials</span> <span>for MDR organisms ≥2 types</span><span>, longer NMBAs and Vasopressors use, and higher CURB-65 score were mortality risk factors in SCAP-Sepsis patients.</span></p>
Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP
ClinicalTrials.gov study NCT01420744. IPD Sharing: Not stated. Countries: 4. Publications: 2.
The mortality risk factor of severe community-acquired pneumonia (SCAP) patients with Sepsis: a retrospective study
Open the record for dataset details and reuse information.
PKM2-TMEM33 axis regulates lipid homeostasis in cancer cells by controling SCAP stability
GEO Series GSE175956. Homo sapiens. 21 samples. Type: Expression profiling by high throughput sequencing.
Cistromic and gene expression analyses associated with HDAC3, SCAP and SREBP1c in mouse livers
GEO Series GSE85929. Mus musculus. 27 samples. Type: Genome binding/occupancy profiling by high throughput sequencing; Expression profiling by high throughput sequencing.
SCAP vs HIFU for Recurrent Prostate Cancer After Radiation Therapy
ClinicalTrials.gov study NCT05044754. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly PatientsAcquired Pneumonia (sCAP) in Elderly Patients"
ClinicalTrials.gov study NCT07070284. IPD Sharing: NO. Countries: 6. Publications: 0.
Determination of Scapulothoracic and Glenohumeral Angles by Imaging in Patients After Shoulder Arthroplasty (SCAP-imag)
ClinicalTrials.gov study NCT06877936. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
ClinicalTrials.gov study NCT05722938. IPD Sharing: NO. Countries: 18. Publications: 0.
Study to Evaluate Two Diagnostic Strategies for the Treatment of Severe Community Acquired Pneumonia (SCAP)
ClinicalTrials.gov study NCT00308659. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The effects of SCAP deletion on gene expression of activated B cells
GEO Series GSE204913. Mus musculus. 16 samples. Type: Expression profiling by high throughput sequencing.
The expression profiling comparison of mice with Scap and Insig deletion from perinatal lung (E17.5-PN1)
GEO Series GSE53397. Mus musculus. 24 samples. Type: Expression profiling by array.
ARMC5 selectively degrades SCAP-free SREBF1 and is essential for fatty acid desaturation in adipocytes
GEO Series GSE262941. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Chromatin accessibility dynamics across C. elegans development and ageing [scap]
GEO Series GSE114490. Caenorhabditis elegans. 12 samples. Type: Expression profiling by high throughput sequencing.
Liver gene expression profile of wild type, liver-specific PTEN KO, SCAP KO and PTEN/SCAP double KO mice.
GEO Series GSE169104. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
Impact of a pro-inflammatory stimulus on the miRNA composition of extracellular vesicles (EV) from stem cells from apical papilla (SCAP)
GEO Series GSE208577. Homo sapiens. 6 samples. Type: Non-coding RNA profiling by high throughput sequencing.
SCAPs Regulate DFSC Differentiation via the Osteoglycin-Hedgehog Pathway
GEO Series GSE209650. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
Transcriptional Profliing of small molecules induced endothelial cells of stem cells from apical papilla (SCAP-ECs), stem cells from apical papilla (SCAP) and human vein endothelial cells (HUVECs)
GEO Series GSE149930. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.